High initial blood levels of tacrolimus in overweight renal transplant recipients

Transplantation Proceedings

Volumn 37, Issue 3, 2005, Pages 1453-1454

  Rodrigo, E ^a,b   De Cos, M A ^a   Sanchez B ^a   Ruiz, J C ^a   Pinera C ^a   Fernandez Fresnedo G ^a   Palomar, R ^a   Perez Ceballos M A ^a   Cotorruelo, J G ^a   Zubimendi, J A ^a   De Francisco, A L M ^a   Arias, M ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; TACROLIMUS;

ADULT; BIOCHEMISTRY; BODY MASS; BODY WEIGHT; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

AREA UNDER CURVE; BODY MASS INDEX; CREATININE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 21044436269     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.02.055     Document Type: Conference Paper

References (5)

1. P. Kelly, B.D. Kahan Review: metabolism of immunosuppressant drugs Curr Drug Metab 3 2002 275
2. N.A. Undre Pharmacokinetics of tacrolimus-based combination therapies Nephrol Dial Transplant 18 Suppl 1 2003 i12
3. N. Perico, P. Ruggenenti, E. Gotti In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. Trial Kidney Int 65 2004 1084
4. A.J. Olyaei, A.M. de Mattos, W.M. Bennet Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies Curr Opin Crit Care 7 2001 384
5. B.D. Maes, D. Kuypers, T. Messiaen Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors Transplantation 72 2001 1655